The genetics of nicotine dependence

Current Psychiatry Reports

Volumn 8, Issue 2, 2006, Pages 158-164

  Li, Ming D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; AMINO ACID DECARBOXYLASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR; NICOTINE;

CANCER MORTALITY; CANCER RISK; CIGARETTE SMOKING; FEMALE; GENE IDENTIFICATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; LUNG CANCER; MALE; PHENOTYPE; POPULATION DISTRIBUTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING HABIT; TOBACCO DEPENDENCE;

BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; HUMANS; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-B; RECEPTORS, NICOTINIC; TOBACCO USE DISORDER;

EID: 33645559825     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-006-0016-0     Document Type: Review

References (58)

1. Centers for Disease Control and Prevention: Cigarette smoking among adults - United States, 2002. Morb Mortal Wkly Rep 2004, 53:427-431.
2. Mokdad AH, Marks JS, Stroup DF, Gerberding JL: Actual causes of death in the United States, 2000. JAMA 2004, 291:1238-1245.
3. Peto R, Darby S, Deo H, et al.: Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. Br Med J 2000, 321:323-329.
4. Vineis P, Alavanja M, Buffler P, et al.: Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004, 96:99-106.
5. Li MD: The genetics of smoking related behavior: a brief review. Am J Med Sci 2003, 326:168-173.
6. Sullivan PF, Kendler KS: The genetic epidemiology of smoking. Nicotine Tob Res 1999, 1:S51-S57.
7. Li MD, Cheng R, Ma JZ, et al.: A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003, 98:23-31.
8. Bergen AW, Korczak JF, Weissbecker KA, et al.: A genome-wide search for loci contributing to smoking and alcoholism. Genet Epidemiol 1999, 17:S55-S60.
9. Duggirala R, Almasy L, Blangero J: Smoking behavior is under the influence of a major quantitative trait locus on human chromosome 5q. Genet Epidemiol 1999, 17:S139-S144.
10. Li MD, Ma JZ, Cheng R, et al.: A genome wide scan to identify loci for smoking quantity in the Framingham Heart Study populations. BMC Gene 2003, 4 (Suppl I): S103.
11. Straub RE, Sullivan PF, Ma Y, et al.: Susceptibility genes for nicotine dependence: a genome scan and followup in an independent sample suggest that regions on chromosomes 2, 4, 10, 16, 17 and 18 merit further study. Mol Psychiatry 1999, 4:129-144.
12. Bierut LJ, Rice JP, Goate A, et al.: A genomic scan for habitual smoking in families of alcoholics: common and specific genetic factors in substance dependence. Am J Med Genet 2004, 124A:19-27.
13. Gelernter J, Liu X, Hesselbrock V, et al.: Results of a genomewide linkage scan: support for chromosomes 9 and 11 loci increasing risk for cigarette smoking. Am J Med Genet 2004, 128B:94-101.
14. Wang D, Ma JZ, Li MD: Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis. Pharmacogenomics J 2005, 5:166-172.
15. Li MD, Ma JZ, Beuten J: Progress in searching for susceptibility loci and genes for smoking-related behavior. Clin Genet 2004, 66:382-392.
16. Munafo MR, Clark TG, Johnstone EC, et al.: The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 2004, 6:583-597.
17. Jonsson EG, Nothen MM, Grunhage F, et al.: Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Mol Psychiatry 1999, 4:290-296.
18. Thompson J, Thomas N, Singleton A, et al.: D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997, 7:479-484.
19. Tyndale RF: Genetics of alcohol and tobacco use in humans. Ann Med 2003, 35:94-121.
20. Kaupmann K, Malitschek B, Schuler V, et al.: GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 1998, 396:683-687.
21. Corrigall WA, Coen KM, Adamson KL, et al.: Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology (Berl) 2000, 149:107-114.
22. Fattore L, Cossu G, Martellotta MC, et al.: Baclofen antagonizes intravenous self-administration of nicotine in mice and rats. Alcohol Alcohol 2002, 37:495-498.
23. Beuten J, Ma JZ, Payne TJ, et al.: Single- and multilocus allelic variants within the GABAB receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am J Hum Genet 2005, 76:859-864.
24. Heatherton TF, Kozlowski LT, Frecker RC, et al.: The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991, 86:1119-1127.
25. Heatherton TF, Kozlowski LT, Frecker RC, et al.: Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989, 84:791-799.
26. Flores CM, Rogers SW, Pabreza LA, et al.: A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Mol Pharmacol 1992, 41:31-37.
27. Marks MJ, Pauly JR, Gross SD, et al.: Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 1992, 12:2765-2784.
28. Whiteaker P, Sharples CG, Wonnacott S: Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol Pharmacol 1998, 53:950-962.
29. Li MD, Beuten J, Ma JZ, et al.: Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 2005, 14:1211-1219.
30. Feng Y, Niu T, Xing H, et al.: A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet 2004, 75:112-121.
31. Lueders KK, Hu S, McHugh L, et al.: Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2). Nicotine Tob Res 2002, 4:115-125.
32. Silverman MA, Neale MC, Sullivan PF, et al.: Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence. Am J Med Genet 2000, 96:646-653.
33. Ma JZ, Beuten J, Payne TJ, et al.: Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum Mol Genet 2005, 14:1691-1698.
34. Matsushita S, Kimura M, Miyakawa T, et al.: Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin Exp Res 2004, 28:1609-1612.
35. Itoh K, Hashimoto K, Shimizu E, et al.: Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan. Am J Med Genet B Neuropsychiatr Genet 2005, 132:70-73.
36. Liu QR, Walther D, Drgon T, et al.: Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease. Am J Med Genet B Neuropsychiatr Genet 2005, 134:93-103.
37. Beuten J, Ma JZ, Payne TJ, et al.: Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am J Med Genet B Neuropsychiatr Genet 2005, 139:73-80.
38. Weinshilboum RM, Otterness DM, Szumlanski CL: Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu Rev Pharmacol Toxicol 1999, 39:19-52.
39. Akil M, Kolachana BS, Rothmond DA, et al.: Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 2003, 23:2008-2013.
40. Gogos JA, Morgan M, Luine V, et al.: Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 1998, 95:9991-9996.
41. David SP, Johnstone E, Griffiths SE, et al.: No association between functional catechol O-methyl transferase 1947A>G polymorphism and smoking initiation, persistent smoking or smoking cessation. Pharmacogenetics 2002, 12:265-268.
42. McKinney EF, Walton RT, Yudkin P, et al.: Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 2000, 10:483-491.
43. Beuten J, Payne TJ, Ma JZ, et al.: Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 2005 [Epub ahead of print].
44. Swan GE, Hudmon KS, Jack LM, et al.: Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation. Cancer Epidemiol Biomarkers Prev 2003, 12:994-1005.
45. Colby SM, Tiffany ST, Shiffman S, et al.: Measuring nicotine dependence among youth: a review of available approaches and instruments. Drug Alcohol Depend 2000, 59:S23-S39.
46. Gilliard J, Bruchon-Schweitzer M: Development and validation of a multidimensional smoking behaviour questionnaire. Psychol Rep 2001, 89:499-509.
47. Moolchan ET, Radzius A, Epstein DH, et al.: The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: do they diagnose the same smokers? Addict Behav 2002, 27:101-113.
48. Shiffman S, Kassel JD, Paty J, et al.: Smoking typology profiles of chippers and regular smokers. J Subst Abuse 1994, 6:21-35.
49. Russell MA, Peto J, Patel UA: The classification of smoking by factorial structure of motives. J Royal Statist Soc Assoc 1974, 137:313-334.
50. Hudmon KS, Marks JL, Pomerleau CS, et al.: A multidimensional model for characterizing tobacco dependence. Nicotine Tob Res 2003, 5:655-664.
51. Fagerstrom KO: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978, 3:235-241.
52. Tiffany ST. A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol Rev 1990, 97:147-168.
53. Shadel WG, Shiffman S, Niaura R, et al.: Current models of nicotine dependence: what is known and what is needed to advance understanding of tobacco etiology among youth. Drug Alcohol Depend 2000, 59:S9-S22.
54. Robinson TE, Berridge KC: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993, 18:247-291.
55. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994.
56. Johnson EO, Breslau N, Anthony JC: The latent dimensionality of DIS/DSM-III-R nicotine dependence: exploratory analyses. Addiction 1996, 91:583-588.
57. Piper ME, Piasecki TM, Federman EB, et al.: A multiple motives approach to tobacco dependence: the Wisconsin Inventory of Smoking Dependence Motives (WISDM-68). J Consult Clin Psychol 2004, 72:139-154.
58. Shiffman S, Hickcox M, Gnys M, et al.: The nicotine dependence syndrome scale: development of a new measure. Annual meeting of the Society for Research on Nicotine and Tobacco: San Diego, CA, 1995.